Concepedia

Author

James Chung

Amgen (United States)ORCID

Also Known As

J B Chung, J Chung, J. B. Chung, J. Chung, J.B. Chung, James B Chung, James B. Chung, James Chung

61

Publications

2K

Citations

23

H-Index

45

Concepts

All Affiliations

Amgen (United States)University of PennsylvaniaSorbonne UniversitéPitié-Salpêtrière HospitalUniversity of Toronto
JC

About

James Chung is an author at Amgen (United States) specializing in medicine, autoimmune disease, and t cell immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

323

2

Allergy

2

2

56

3

Cell Biology

2

2

183

4

Health Sciences

1

1

32

5

Emergency Medicine

1

1

32

James Chung

×

27

Publications

1.4K

Citations

19

H-Index

YearCitations

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase <scp>III</scp> Trial

Philip J. Mease, Dafna D. Gladman, David H. Collier,

Arthritis & Rheumatology

2019

209

B7RP-1 Blockade Ameliorates Autoimmunity through Regulation of Follicular Helper T Cells

Yiling Hu, Daniela Metz, James Chung,

The Journal of Immunology

2009

137

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

Melvin Churchill, Luis Felipe Flores-Suárez, Mario H. Cardiel,

Arthritis Research & Therapy

2013

105

CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals

James Chung, Richard A. Sater, Michele L. Fields,

International Immunology

2002

91

Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis undergoing immunosuppressive therapy

James Chung, Katrina Armstrong, J. Sanford Schwartz,

Arthritis & Rheumatism

2000

79

Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti–Interferon‐γ Antibody, in Patients With Discoid Lupus Erythematosus

Victoria P. Werth, David Fiorentino, Barbara Sullivan,

Arthritis & Rheumatology

2017

75

Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus

Barbara Sullivan, Wayne Tsuji, Alan Kivitz,

Lupus Science & Medicine

2016

71

Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus

Andrew A. Welcher, Michael Boedigheimer, Alan Kivitz,

Arthritis & Rheumatology

2015

70

Brief Report: A Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled, Multiple‐Dose Study to Evaluate <scp>AMG</scp> 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis

Laurence E. Cheng, Zahir Amoura, Benjamin C. Cheah,

Arthritis & Rheumatology

2018

69

Cutting Edge: Differential Sequestration of Plasma Membrane-Associated B Cell Antigen Receptor in Mature and Immature B Cells into Glycosphingolipid-Enriched Domains

James Chung, Mark A. Baumeister, John G. Monroe

The Journal of Immunology

2001

64

Page 1